Significance of expression of tumor-associated microRNA-21 and -375 for predicting the course of cancer of oral cavity
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-1.15884Keywords:
aggressiveness, microRNA-21, microRNA-375, oral cancer, survivalAbstract
Aim: To investigate the features of expression of miRNA-21 and miRNA-375 in tumor cells of patients with cancer of oral cavity (COC) and to determine the possibility of their use to predict the aggressiveness of COC course. Materials and Methods: The work is based on the results of examination and treatment of 50 patients with stage II–IV COC. miRNA expression in tumor cells was analyzed by real time reverse transcription polymerase chain reaction. Results: High levels of miRNA-21 expression (> 0.26 a.u.) and miRNA-375 (> 0.36 a.u.) were determined in 72.0% and 63.0% of cases. We revealed a tendency to decreased miRNA-21 expression and increased miRNA-375 expression in tumors of patients with recurrence-free survival less than 12 months and the presence of metastatic lesions in regional lymph nodes. In patients with COC of low differentiation grade, the level of miRNA-21 was 2.0 times lower compared with tumors of moderate differentiation grade (p < 0.05), while the expression of miRNA-375, on the contrary, was higher in tumors of low differentiation grade. A decreased expression of miRNA-21 (< 0.26 a.u.) against the background of decreased levels of miRNA-375 (< 0.36 a.u.) in tumor cells was associated with worse recurrence-free survival. Conclusions: The obtained results indicate the relation between the main clinical and pathological characteristics of patients with COC and the levels of miRNA-21 and -375 expression in tumor tissue, which indicates the involvement of these miRNAs in the formation of COC malignancy evidencing on their potential usefulness as additional prognostic markers.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424.
Montero PH, Patel SG. Cancer of the oral cavity. Surg Oncol Clin N Am 2015; 24: 491–508.
Rupaimoole R, Slack FJ. MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 2017; 16: 203–22.
Mazumder S, Datta S, Ray, JG, et al. Liquid biopsy: miRNA as a potential biomarker in oral cancer. Cancer Epidemiol 2019; 58: 137–45.
Gombos K, Horvath R, Szele E, et al. miRNA expression profiles of oral squamous cell carcinomas. Anticancer Res 2013; 33: 1511–7.
Zeljic K, Jovanovic I, Jovanovic J, et al. MicroRNA meta-signature of oral cancer: evidence from a meta-analysis. Upsala J Med Sci 2018; 123: 43–9.
Fang C, Li Y. Prospective applications of microRNAs in oral cancer. Oncol Lett 2019; 18: 3974–84.
Kramer MF. Stem–loop RT-qPCR for miRNAs. Curr Prot Mol Biol 2011; 95: 15–20.
Redshaw N, Wilkes T, Whale A, et al. A comparison of miRNA isolation and RT-qPCR technologies and their effects on quantification accuracy and repeatability. Biotechniques 2013; 54: 155–64.
Dai Y, Xie CH, Neis JP, et al. MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance. Head & Neck 2011; 33: 786–91.
Momen-Heravi F, Trachtenberg AJ, Kuo WP, et al. Genomewide study of salivary microRNAs for detection of oral cancer. J Dental Res 2014; 93: 86S–93S.
Lamperska KM, Kozlowski P, Kolenda T, et al. Unpredictable changes of selected miRNA in expression profile of HNSCC. Cancer Biomarkers 2016; 16: 55–64.
Schneider A, Lopez VB, Suchorska YN, et al. Tissue and serum microRNA profile of oral squamous cell carcinoma patients. Sci Rep 2018; 8: 1–8.
Tsai SC, Huang SF, Chiang JH, et al. The differential regulation of microRNAs is associated with oral cancer. Oncol Rep 2017; 38: 1613–20.
Shi W, Yang J, Li S, et al. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5. Oncotarget 2015; 37: 40172.
Shah S, Jadhav K, Shah V, et al. miRNA 21: diagnostic prognostic and therapeutic marker for oral cancer. MicroRNA 2016; 5: 175–9.
He Q, Chen Z, Cabay RJ, Zhang L, et al. microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection. Oral Oncol 2016; 57: 15–20.
Yoon AJ, Wang S, Shen J, et al. Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma. Am J Transl Res 2014; 6: 580.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.